摘要
目的:评价阿立哌唑治疗女性精神分裂症患者的疗效和副反应。方法:对70例女性精神分裂症患者随机分为阿立哌唑组和喹硫平组治疗8周,采用阳性症状与阴性症状量表(PANSS)、副反应量表(TESS)评定疗效和副反应。结果:阿立哌唑与喹硫平疗效相当,但其副反应轻,服用方便,依从性好。结论:阿立哌唑治疗女性精神分裂症患者疗效确切,值得推广使用。
Objective ： To compare the efficacy and side effects of Aripiprazole and Quetiapine in the treatment of woman schizophrenia. Methods： 70 patients of woman schizophrenia were randomly divided into Aripiprazole group and Quetiapine group for 8 weeks. Effects and side reactions were evaluated with positive and negative syndrome scale （PANSS） and treatment emergent symptoms scale（TESS） before and after treatment, Results： The therapeutic efficacy in Aripiprazole group was similar to that in Venlafaxine. The efficacy in Aripiprazole group had fewer side effects, taking conveniently and a good compliance. Conclusion： Aripiprazole is effective in treatment of woman schizophrenia. It is worthwhile generalization and use.
出处
《华夏医学》
CAS
2009年第2期213-215,共3页
Acta Medicinae Sinica
